已发表论文

库奇尤单抗治疗斑块型银屑病出现白塞氏病样药物反应

 

Authors Wei Y, Zhang P, Chuan J, Ye J, Liu T

Received 16 September 2025

Accepted for publication 18 December 2025

Published 8 January 2026 Volume 2026:19 567115

DOI https://doi.org/10.2147/CCID.S567115

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Prof. Dr. Rungsima Wanitphakdeedecha

Yanjie Wei,1,* Peilian Zhang,2,* Jintao Chuan,1 Jianzhou Ye,2 Tao Liu3 

1Department of Dermatology, The First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine, Kunming, People’s Republic of China; 2Department of Dermatology, Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, Yunnan, People’s Republic of China; 3Department of Pathology, Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, Yunnan, People’s Republic of China

*These authors contributed equally to this work

Correspondence: Peilian Zhang, Department of Dermatology, Yunnan Provincial Hospital of Traditional Chinese Medicine, Kunming, People’s Republic of China, Email mzczpl1968@163.com
摘要 

目的:本报告旨在介绍一例罕见的反常反应表现为白塞氏病样的特征,在接受司库奇尤单抗治疗银屑病 3 个月后出现的不良反应。

患者与方法:一名38岁女性患者,有近30年的银屑病病史。该患者在接受七剂司库奇尤单抗治疗后(总剂量为2100mg),银屑病病情明显改善然而,她出现了咽喉疼痛、扁桃体及外生殖器疼痛性溃疡,躯干、四肢毛囊炎样丘疹以及双下肢伸侧结节性红斑皮损等不良反应。实验室检查未发现感染证据皮肤活检的组织病理学示浅层和深层血管周围及间质炎症,伴有大量淋巴细胞、中性粒细胞和嗜酸性粒细胞浸润该患者被诊断为司库奇尤单抗诱发的类似白塞氏病。立即停用司库奇尤单抗,给予沙利度胺 50mg 每日三次;秋水仙碱 50mg每日两次治疗

结果:治疗周后,口腔及外生殖器溃疡消退,躯干、四肢毛囊炎样丘疹、结节性红斑好转仅留下色素沉着。后改用乌司奴单抗标准剂量规律治疗,银屑病控制佳,随访4年,未见白塞病样皮疹复发。

结论:我们的报告旨在提醒医生在临床诊断和治疗过程中,必须对患者进行密切随访,以发现抗IL17治疗中可能出现的这种不常见但重要的矛盾应。此外,明确不良反应的发生时间至关重要,这有助于临床医生及时采取预防措施,降低风险,并迅速识别不良反应。